We are live on ! Find out more
U

UBS Portfolio holdings

AUM $136B
1-Year Est. Return 16.36%
This Fund
S&P 500
This Quarter Est. Return
-0.23%
1 Year Est. Return
+16.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$136B
AUM Growth
+$7.83B
Cap. Flow
+$9.38B
Cap. Flow %
6.92%
Top 10 Hldgs %
13.26%
Holding
11,505
New
1,063
Increased
4,755
Reduced
3,911
Closed
1,116

Sector Composition

Rank Sector Weight
1 Energy 8.49%
2 Technology 6.67%
3 Healthcare 6.67%
4 Financials 6.58%
5 Industrials 5.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IRL
6326
DELISTED
NEW IRELAND FUND INC
IRL
$75K ﹤0.01%
5,957
-11,319
-66% -$149K
RRTS
6327
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
$75K ﹤0.01%
131
+35
+36% +$22.8K
BKS
6328
PUT
DELISTED
Barnes & Noble
BKS
$75K ﹤0.01%
5,799
-14,344
-71% -$210K
RDEN
6329
CALL
DELISTED
ELIZABETH ARDEN INC
RDEN
$75K ﹤0.01%
4,500
+2,300
+105% +$43.6K
ERW
6330
DELISTED
EXCHANGE TRADED CONCEPTS TR JANUS EQL RISK WGTD LRG CAP ETF
ERW
$75K ﹤0.01%
1,340
-52
-4% -$2.94K
RGP
6331
CALL
DELISTED
REGENCY ENERGY PARTNERS LP COMMON UTS REP LIMITED PART INTS
RGP
$75K ﹤0.01%
2,300
+800
+53% +$25.4K
VE
6332
CALL
DELISTED
VEOLIA ENVIRONNEMENT
VE
$75K ﹤0.01%
4,300
-900
-17% -$16K
IBCB
6333
DELISTED
ISHARES IBONDS MAR 2016 CORPORATE EX-FINANCIALS ETF
IBCB
$75K ﹤0.01%
750
-874
-54% -$87.3K
BBH icon
6334
CALL
VanEck Biotech ETF
BBH
$405M
$74K ﹤0.01%
700
-2,800
-80% -$283K
EWC icon
6335
CALL
iShares MSCI Canada ETF
EWC
$6.17B
$74K ﹤0.01%
2,400
-1,600
-40% -$51.5K
GVA icon
6336
Granite Construction
GVA
$5.03B
$74K ﹤0.01%
2,322
+432
+23% +$14.9K
ITB icon
6337
PUT
iShares US Home Construction ETF
ITB
$2.29B
$74K ﹤0.01%
3,300
-1,400
-30% -$32.9K
MKC icon
6338
CALL
McCormick & Company Non-Voting
MKC
$13.7B
$74K ﹤0.01%
2,200
-200
-8% -$6.88K
VTR icon
6339
PUT
Ventas
VTR
$44.7B
$74K ﹤0.01%
1,051
+438
+71% +$32K
WF icon
6340
Woori Financial
WF
$17.1B
$74K ﹤0.01%
2,011
+199
+11% +$7.76K
ADRD
6341
DELISTED
Invesco BLDRS Developed Markets 100 ADR Index Fund
ADRD
$74K ﹤0.01%
3,049
-51
-2% -$1.28K
SDT
6342
DELISTED
SANDRIDGE MISSISSIPPIAN TRUST I
SDT
$74K ﹤0.01%
17,936
+3,724
+26% +$21K
BXE
6343
DELISTED
Bellatrix Exploration Ltd.
BXE
$74K ﹤0.01%
2,398
-2,804
-54% -$105K
NES
6344
PUT
DELISTED
NUVERRA ENVIRONMENTAL INC NEW COM STK (DE)
NES
$74K ﹤0.01%
5,000
+1,000
+25% +$15.9K
DRGS
6345
DELISTED
RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS
DRGS
$74K ﹤0.01%
+1,460
New +$72.1K
PEOP
6346
DELISTED
PEOPLES FED BANCSHARES INC COM STK (MD)
PEOP
$74K ﹤0.01%
3,694
+3,594
+3,594% +$69.6K
SKK
6347
DELISTED
PROSHARES ULTRASHORT RUSSELL 2000 GROWTH
SKK
$74K ﹤0.01%
1,777
+1,005
+130% +$40K
AWR icon
6348
CALL
American States Water
AWR
$3.37B
$73K ﹤0.01%
2,400
-15,200
-86% -$478K
BOIL icon
6349
ProShares Ultra Bloomberg Natural Gas
BOIL
$340M
0
EWH icon
6350
CALL
iShares MSCI Hong Kong ETF
EWH
$1.25B
$73K ﹤0.01%
3,600
+200
+6% +$4.33K

Similar funds

UBS's Q3 2014 Portfolio in Review

As of Q3 2014, UBS held 11,505 positions worth $136B, up 6.1% from $128B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS deployed $9.38B of net new capital in Q3 2014, opening 1,063 new positions and adding to 4,755 existing holdings. Its largest new stake was Alibaba: 1,105,926 shares worth $98.3M.

By sector, the portfolio is most concentrated in Energy at 8.5% of assets, down from 8.8% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.62B trimmed.

  • UBS's largest Q3 2014 buy was Alibaba: 1,105,926 shares worth $98.3M.
  • UBS added most to Amgen in Q3 2014, an estimated $387M increase.
  • UBS's biggest Q3 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.62B.
  • UBS fully exited SUSSER HOLDINGS CORPORATION COMMON STOCK in Q3 2014, selling an estimated $81.1M.
  • UBS's ten largest holdings make up 13% of its $136B portfolio in Q3 2014.
  • UBS opened 1,063 new positions and closed 1,116 in Q3 2014.
  • UBS's portfolio value rose 6.1% quarter-over-quarter to $136B.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.